Background: Breast cancer (BC) is one of the most common female cancers. Clinical and histopathological information is collectively used for diagnosis, but is often not precise. We applied machine learning (ML) methods to identify the valuable gene signature model based on differentially expressed genes (DEGs) for BC diagnosis and prognosis. Methods: A cohort of 701 samples from 11 GEO BC microarray datasets was used for the identification of significant DEGs. Seven ML methods, including RFECV-LR, RFECV-SVM, LR-L1, SVC-L1, RF, and Extra-Trees were applied for gene reduction and the construction of a diagnostic model for cancer classification. Kaplan–Meier survival analysis was performed for prognostic signature construction. The potential biomarkers were confirmed via qRT-PCR and validated by another set of ML methods including GBDT, XGBoost, AdaBoost, KNN, and MLP. Results: We identified 355 DEGs and predicted BC-associated pathways, including kinetochore metaphase signaling, PTEN, senescence, and phagosome-formation pathways. A hub of 28 DEGs and a novel diagnostic nine-gene signature (COL10A, S100P, ADAMTS5, WISP1, COMP, CXCL10, LYVE1, COL11A1, and INHBA) were identified using stringent filter conditions. Similarly, a novel prognostic model consisting of eight-gene signatures (CCNE2, NUSAP1, TPX2, S100P, ITM2A, LIFR, TNXA, and ZBTB16) was also identified using disease-free survival and overall survival analysis. Gene signatures were validated by another set of ML methods. Finally, qRT-PCR results confirmed the expression of the identified gene signatures in BC. Conclusion: The ML approach helped construct novel diagnostic and prognostic models based on the expression profiling of BC. The identified nine-gene signature and eight-gene signatures showed excellent potential in BC diagnosis and prognosis, respectively.

This systematic review examines EEG-based imagined speech classification, emphasizing directional words essential for development in the brain–computer interface (BCI). This study employed a structured methodology to analyze approaches using public datasets, ensuring systematic evaluation and validation of results. This review highlights the feature extraction techniques that are pivotal to classification performance. These include deep learning, adaptive optimization, and frequency-specific decomposition, which enhance accuracy and robustness. Classification methods were explored by comparing traditional machine learning with deep learning and emphasizing the role of brain lateralization in imagined speech for effective recognition and classification. This study discusses the challenges of generalizability and scalability in imagined speech recognition, focusing on subject-independent approaches and multiclass scalability. Performance benchmarking across various datasets and methodologies revealed varied classification accuracies, reflecting the complexity and variability of EEG signals. This review concludes that challenges remain despite progress, particularly in classifying directional words. Future research directions include improved signal processing techniques, advanced neural network architectures, and more personalized, adaptive BCI systems. This review is critical for future efforts to develop practical communication tools for individuals with speech and motor impairments using EEG-based BCIs.

Autism spectrum disorder (ASD) affects approximately 1.4% of the population and imposes significant social and economic burdens. Because its etiology is unknown, effective diagnosis is challenging. Advancements in structural magnetic resonance imaging (sMRI) allow for the objective assessment of ASD by examining structural brain changes. Recently, machine learning (ML)-based diagnostic systems have emerged to expedite and enhance the diagnostic process. However, the expected success in ASD was not yet achieved. This study evaluates and compares the performance of seven optimized ML models to identify sMRI-based biomarkers for early and accurate detection of ASD in children aged 5 to 10 years. The effect of using hyperparameter tuning and feature selection techniques are investigated using two public datasets from Autism Brain Imaging Data Exchange Initiative. Furthermore, these models are tested on a local Saudi dataset to verify their generalizability. The integration of the grey wolf optimizer with a support vector machine achieved the best performance with an average accuracy of 71% (with further improvement to 71% after adding personal features) using 10-fold Cross-validation. The optimized models identified relevant biomarkers for diagnosis, lending credence to their truly generalizable nature and advancing scientific understanding of neurological changes in ASD.

For years, several countries have been concerned about how to dispose of unused pharmaceuticals that can endanger human health and the environment. Moreover, some people are in desperate need of medical attention and medications, but they lack the financial resources to obtain them. In Saudi Arabia, there are no take-back medicine programs, and there is no published research on how medications properly are disposed. The aim of this research is to use the power of artificial intelligence to assist in the proper management and disposal of expired and unused medications and to develop a prototype device for collecting medication by automatically classifying medications for proper disposal and donation. In this research, artificial intelligence technologies such as web-based expert systems, image recognition and classification algorithms, chatbots, and the internet of things are used to assist in a take-back medications program. In conclusion, the prototype design of a web-based expert system and the device reduced improper disposal risks by providing significant advice on the safe disposal of unwanted pharmaceuticals. By using an organized method of collecting expired medications, the benefits were made possible.

Medicines are used daily in Saudi Arabian homes. However, when these medicines are no longer needed, most people dispose of them incorrectly, forgetting the harmful impact of improper disposal. Inadequate awareness and knowledge are major reasons for improper disposal. In this study, we create a broad inclusive knowledge base that includes many types of medications available in Saudi homes and provides guidance on how to dispose of them as a means of raising awareness on correct disposal methods and preventing harmful impacts on both the environment and society. The study primarily aims to understand societal behaviour regarding the disposal of unused and expired medications and develop a prototype of a knowledge‐based system that helps raise awareness of correct disposal methods for unused and expired medications. The data in the knowledge base are presented in tables that are easy to understand and comprehend, and the recommendations are also easy to apply and practice in everyday life. The results from the survey show that 66.8% of the 310 participants had unneeded medications in their homes, and only 14.9% knew how to dispose of unusable medications, while only 6.5% knew how to dispose of expired medications. Overall, the research studied Saudi society’s behaviour regarding unused and expired medications, and we created a prototype of a knowledge‐based system designed to increase awareness of proper disposal and management of unused and expired medications.

The use of intelligent techniques in medicine has brought a ray of hope in terms of treating leukaemia patients. Personalized treatment uses patient’s genetic profile to select a mode of treatment. This process makes use of molecular technology and machine learning, to determine the most suitable approach to treating a leukaemia patient. Until now, no reviews have been published from a computational perspective concerning the development of personalized medicine intelligent techniques for leukaemia patients using molecular data analysis. This review studies the published empirical research on personalized medicine in leukaemia and synthesizes findings across studies related to intelligence techniques in leukaemia, with specific attention to particular categories of these studies to help identify opportunities for further research into personalized medicine support systems in chronic myeloid leukaemia. A systematic search was carried out to identify studies using intelligence techniques in leukaemia and to categorize these studies based on leukaemia type and also the task, data source, and purpose of the studies. Most studies used molecular data analysis for personalized medicine, but future advancement for leukaemia patients requires molecular models that use advanced machine-learning methods to automate decision-making in treatment management to deliver supportive medical information to the patient in clinical practice.